Anna Furimsky

521 total citations
18 papers, 439 citations indexed

About

Anna Furimsky is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Biochemistry. According to data from OpenAlex, Anna Furimsky has authored 18 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Public Health, Environmental and Occupational Health and 4 papers in Biochemistry. Recurrent topics in Anna Furimsky's work include Sirtuins and Resveratrol in Medicine (3 papers), Estrogen and related hormone effects (3 papers) and Traditional and Medicinal Uses of Annonaceae (3 papers). Anna Furimsky is often cited by papers focused on Sirtuins and Resveratrol in Medicine (3 papers), Estrogen and related hormone effects (3 papers) and Traditional and Medicinal Uses of Annonaceae (3 papers). Anna Furimsky collaborates with scholars based in United States, Puerto Rico and Canada. Anna Furimsky's co-authors include Lalitha Iyer, Carol E. Green, Irving W. Wainer, Izet M. Kapetanović, Wattana Weerachatyanukul, Swarajya Lakshmi Vattem Venkata, Michael E. Goldberg, Nongnuj Tanphaichitr, Mary J. Tanga and Jon C. Mirsalis and has published in prestigious journals such as PLoS ONE, The FASEB Journal and Journal of Medicinal Chemistry.

In The Last Decade

Anna Furimsky

18 papers receiving 433 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Furimsky United States 10 153 82 81 78 49 18 439
Sonu Chand Thakur India 16 224 1.5× 55 0.7× 62 0.8× 65 0.8× 2 0.0× 41 614
Lee Williams United States 14 353 2.3× 53 0.6× 29 0.4× 31 0.4× 6 0.1× 28 857
Laïla El Kihel France 12 161 1.1× 114 1.4× 32 0.4× 19 0.2× 7 0.1× 22 337
Paula M. Brito Portugal 11 257 1.7× 35 0.4× 17 0.2× 25 0.3× 105 2.1× 15 571
Paul Catz United States 13 98 0.6× 72 0.9× 11 0.1× 64 0.8× 20 0.4× 20 420
Rackhyun Park South Korea 12 230 1.5× 22 0.3× 19 0.2× 21 0.3× 16 0.3× 28 639
Chinmoy Banerjee India 11 214 1.4× 60 0.7× 31 0.4× 56 0.7× 13 0.3× 18 462
Merve Baysal Türkiye 14 122 0.8× 247 3.0× 103 1.3× 53 0.7× 1 0.0× 34 567
Sneha B. Bansode India 11 170 1.1× 44 0.5× 47 0.6× 18 0.2× 5 0.1× 18 630
Chang‐Bo Zheng China 13 182 1.2× 34 0.4× 67 0.8× 44 0.6× 11 0.2× 54 464

Countries citing papers authored by Anna Furimsky

Since Specialization
Citations

This map shows the geographic impact of Anna Furimsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Furimsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Furimsky more than expected).

Fields of papers citing papers by Anna Furimsky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Furimsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Furimsky. The network helps show where Anna Furimsky may publish in the future.

Co-authorship network of co-authors of Anna Furimsky

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Furimsky. A scholar is included among the top collaborators of Anna Furimsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Furimsky. Anna Furimsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Lee, Min S., Deborah I. Bunin, Anna Furimsky, et al.. (2023). Novel progestogenic androgens for male contraception: design, synthesis, and activity of C7 α-substituted testosterone. Biology of Reproduction. 109(6). 851–863. 1 indexed citations
2.
Curreli, Francesca, Dmitry S. Belov, Young Do Kwon, et al.. (2018). Structure-based lead optimization to improve antiviral potency and ADMET properties of phenyl-1H-pyrrole-carboxamide entry inhibitors targeted to HIV-1 gp120. European Journal of Medicinal Chemistry. 154. 367–391. 39 indexed citations
3.
Velez‐Carrasco, Wanda, Carol E. Green, Paul Catz, et al.. (2015). Pharmacokinetics and Metabolism of 4R-Cembranoid. PLoS ONE. 10(3). e0121540–e0121540. 16 indexed citations
4.
Choi, Taylor A., Anna Furimsky, Robert R. Swezey, et al.. (2015). In Vitro Metabolism and Stability of the Actinide Chelating Agent 3,4,3-LI(1,2-HOPO). Journal of Pharmaceutical Sciences. 104(5). 1832–1838. 17 indexed citations
5.
Werbovetz, Karl A., Edward S. Riccio, Anna Furimsky, et al.. (2014). Evaluation of Antitrypanosomal Dihydroquinolines for Hepatotoxicity, Mutagenicity, and Methemoglobin Formation In Vitro. International Journal of Toxicology. 33(4). 282–287. 2 indexed citations
6.
Ferchmin, P.A., et al.. (2013). Pharmacokinetics and toxicity of a neuroprotective cembranoid. Biochemical Pharmacology. 86(8). 1233–1233. 1 indexed citations
7.
Lowes, David J., Anupam Pradhan, Lalitha Iyer, et al.. (2012). Lead Optimization of Antimalarial Propafenone Analogues. Journal of Medicinal Chemistry. 55(13). 6087–6093. 11 indexed citations
8.
Zhang, Yiqun, Julie Clark, Michele Connelly, et al.. (2012). Lead Optimization of 3-Carboxyl-4(1H)-Quinolones to Deliver Orally Bioavailable Antimalarials. Journal of Medicinal Chemistry. 55(9). 4205–4219. 72 indexed citations
9.
Iyer, Lalitha, Anuradha Ramamoorthy, Ewelina Rutkowska, et al.. (2012). The Stereoselective Sulfate Conjugation of 4′‐Methoxyfenoterol Stereoisomers by Sulfotransferase Enzymes. Chirality. 24(10). 796–803. 4 indexed citations
10.
11.
Green, Carol E., Robert R. Swezey, James Bakke, et al.. (2010). Improved oral bioavailability in rats of SR13668, a novel anti-cancer agent. Cancer Chemotherapy and Pharmacology. 67(5). 995–1006. 8 indexed citations
12.
Siluk, Danuta, Donald E. Mager, Hyunsook Kim, et al.. (2009). Pharmacokinetics and metabolism of (R,R)-methoxyfenoterol in rat. Xenobiotica. 40(3). 195–206. 6 indexed citations
13.
Furimsky, Anna, Carol E. Green, Paul Catz, et al.. (2007). Effect of Resveratrol on 17β-Estradiol Sulfation by Human Hepatic and Jejunal S9 and Recombinant Sulfotransferase 1E1. Drug Metabolism and Disposition. 36(1). 129–136. 22 indexed citations
14.
Furimsky, Anna, Mark N. Ho, Yi Li, et al.. (2006). Glucuronidation oftrans-resveratrol by human liver and intestinal microsomes and UGT isoforms. Journal of Pharmacy and Pharmacology. 58(4). 469–479. 61 indexed citations
15.
Furimsky, Anna, et al.. (2006). Inhibition of human hepatic and jejunal estradiol sulfation by resveratrol and piceatannol. The FASEB Journal. 20(4). 1 indexed citations
16.
17.
Iyer, Lalitha, Mark N. Ho, Anna Furimsky, et al.. (2004). In vitro metabolism and interaction studies with celecoxib and lovastatin.. 64. 488–488. 2 indexed citations
18.
Weerachatyanukul, Wattana, Manee Rattanachaiyanont, Eurı́dice Carmona, et al.. (2001). Sulfogalactosylglycerolipid is involved in human gamete interaction. Molecular Reproduction and Development. 60(4). 569–578. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sonu Chand Thakur Breakdown of academic impact, for papers by Lee Williams Breakdown of academic impact, for papers by Laïla El Kihel Breakdown of academic impact, for papers by Paula M. Brito Breakdown of academic impact, for papers by Paul Catz Breakdown of academic impact, for papers by Rackhyun Park Breakdown of academic impact, for papers by Chinmoy Banerjee Breakdown of academic impact, for papers by Merve Baysal Breakdown of academic impact, for papers by Sneha B. Bansode Breakdown of academic impact, for papers by Chang‐Bo Zheng
Rankless by CCL
2026